Tiaan Consumer (540108)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Current price of ₹2.79 is only 0.43 times book value of ₹6.51, offering a Graham-style margin of safety on a price-to-book basis.
• The ₹3 Cr market cap is tiny, so even a modest asset realization or operating revival could have an outsized impact per share.
• Personal care is a consumer staple category, so any credible restart of operations has a large potential market.
• No dividend is being paid, meaning whatever capital exists is being retained rather than distributed while the situation is unresolved.

Concerns

• Latest quarterly sales and net profit are effectively ₹0 Cr, while annual sales growth is -28.57%, indicating dormant or collapsing operations.
• Profit growth of -160% and ROE of -1.35% show the company is currently destroying shareholder value.
• Piotroski F-Score of 2/9 signals very weak financial health and limited margin for error.
• Promoter holding is not disclosed, so ownership alignment and governance cannot be assessed.

AI Analysis

Look at this and I am reminded of Graham's cigar butt, but I worry the last puff may be soggy. Tiaan Consumer trades at ₹2.79 against book value of ₹6.51, a discount of roughly 57%. That seems cheap, but the latest quarter shows sales of ₹0 Cr and net profit of ₹0 Cr. Annual sales are down 28.57%, and profit has fallen 160%. This is not a business; it is a balance sheet. In personal care, value comes from brands, distribution recall and customer trust. Tiaan has none of those visible in the figures. ROE is -1.35%, ROCE is -0.01%, and the Piotroski F-Score is 2/9, a red flag. A P/E of 0.00 is not cheapness; it is an absence of earnings. With a market cap of only ₹3 Cr, this is a microcap, and with unknown promoter holding, governance itself is a question. I cannot put cash into operations that are not earning. The only attraction is the asset value: if ₹6.51 book value is real and recoverable, the current price offers a substantial margin of safety. But book value can shrink or prove illusory. I need evidence: what are the assets? Cash? Inventory? Receivables? Are losses consuming book value? Is management trying to unlock value or just preserving a listed shell? If the assets are sold and capital returned, this could be interesting. But Graham taught me to buy with a margin of safety; selling at 0.43 times book is one, but a poor business at a discount can still be poor. I will not speculate on a turnaround without proof. I would rather wait for sales, a restructuring, or a clearer asset-backing story. Until then, this is an asset play, not a compounder.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer